Browse studies

Find your next paid study

91 recruiting studies matching your filters

A Phase Ib/II, Multicenter, Open-Label Study to Evaluate Safety, Efficacy, and Pharmacokinetics of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors

This is a phase Ib/II, multicenter, open-label study of YL201 combined with atezolizumab. The study will include 2 parts. Part 1 of the study is a dose escalat…

Thoracic Neoplasms, Lung Diseases, Small Cell Lung Carcinoma

Estimated

~$150 – $4,200

Actual pay is set by the research site.

MediLink Therapeutics (Suzhou) Co., Ltd.NCT07407933

Allogeneic Hematopoietic Cell Transplantation for Refractory Systemic Juvenile Idiopathic Arthritis: A Single-Center Prospective Trial

The goal of this study is to collect clinical data and samples and to evaluate the feasibility of allogeneic hematopoietic cell transplantation (HCT) in childr…

Refractory Systemic Juvenile Idiopathic ArthritisSystemic Juvenile Idiopathic ArthritisSystemic Juvenile Idiopathic Arthritis Associated Lung Disease

Estimated

~$10 – $675

Actual pay is set by the research site.

Children's Hospital Medical Center, CincinnatiNCT07845942

Phase 3

A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (WHO Group 3)

The purpose of this study is to find out if L606 is safe and if it helps people with high blood pressure in the lungs (pulmonary hypertension) caused by inters…

Pulmonary Hypertension Due to Lung Disease (Disorder)

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Liquidia Technologies, Inc.NCT07285655

Phase 1

A Phase 1b/2a, Clinical Trial to Evaluate the Safety, Tolerability, and Exploratory Activity of Small Mobile Stem Cells (SMS) Delivered Into the Lung as a Potential Organ Regeneration Therapy in Moderate to Severe Chronic Obstructive Pulmonary Disease (SORT-COPD Study II)

This study is a phase 1b/2a, open-label, non-randomized, observation of 125 adults, with moderate to severe chronic obstructive pulmonary disease, treated with…

Chronic Obstructive Lung Disease

Estimated

~$150 – $4,200

Actual pay is set by the research site.

SMSbiotechNCT07871890

A Single-Center Observational Biomarker Investigation of Response to Bacteriophage Treatment for Bacterial Infection

This study aims to identify biomarkers associated with response to phage therapy for refractory bacterial infections. This includes mycobacteriophage treatment…

Nontuberculous Mycobacterial Lung Disease

Estimated

Pay not disclosed — ask the coordinator

NYU Langone HealthNCT07076238

Phase 2

A Phase 2A, Open-Label Single Arm Multicenter Exploratory Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Doses of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH).

This study evaluates the effect of ROC-101 in adults with either Pulmonary Arterial Hypertension (PAH) or Pulmonary Hypertension Associated with Interstitial L…

Pulmonary Arterial Hypertension (PAH)Pulmonary Hypertension, Interstitial Lung Disease

Estimated

~$75 – $2,800

Actual pay is set by the research site.

AllRock Bio, Inc.NCT07175038

The American Lung Association (ALA) Lung Health Cohort

The ALA-LHC is a longitudinal, multi-center cohort study that will enroll approximately 4,000 young adults between the ages of 25-35 who do not have severe lun…

Lung Diseases

Estimated

~$10 – $750

Actual pay is set by the research site.

Johns Hopkins UniversityNCT04543461

Observational

Point of Care Lung Ultrasound Examination in Patients With Shortness of Breath

This is a prospective, non-randomized clinical validation research study. Subjects will consent and have two ultrasounds as part of the study.

Lung DiseaseLung Ultrasound

Estimated

~$10 – $1,125

Actual pay is set by the research site.

GE HealthcareNCT07046234

Data Collection Using Eko Digital Devices in a Clinical Setting

The purpose of this research is to prospectively train and validate an artificial intelligence machine learning (ML) algorithm to detect the presence of advent…

Lung Diseases

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Eko Devices, Inc.NCT07227376

Phase 2

Platform Clinical Study for Conquering Scleroderma: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2b Platform Clinical Study to Evaluate the Safety and Efficacy of Investigational Products in Participants With Interstitial Lung Disease Secondary to Systemic Sclerosis

The goal of this clinical trial is to test efficacy of different investigational products (IPs) compared with placebo on the change from baseline to the end of…

Interstitial Lung Disease Due to Systemic DiseaseScleroderma

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Scleroderma Research Foundation, Inc.NCT06195072

Observational

MOBoxy: MoblO2 to Maintain Oxygenation

Many patients with chronic lung disease (e.g., chronic obstructive pulmonary disease (COPD) or interstitial lung disease (ILD)) require supplemental oxygen (O2…

COPDInterstitial Lung Disease

Estimated

~$10 – $1,125

Actual pay is set by the research site.

National Jewish HealthNCT07222592

Phase 2

AN INTERVENTIONAL, OPEN-LABEL, PHASE 2 STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF PF-08634404 MONOTHERAPY OR IN COMBINATION IN ADULT PARTICIPANTS WITH EARLY-STAGE RESECTABLE OR LOCALLY ADVANCED UNRESECTABLE NON-SMALL CELL LUNG CANCER

This study is being done to learn more about a new medicine called PF-08634404. The study team wants to understand how well it works when given alone or with c…

CarcinomaNon-Small-Cell LungLung Cancer (NSCLC)+6 more

Estimated

~$75 – $3,000

Actual pay is set by the research site.

PfizerNCT07489066